JLGQX
Price
$80.22
Change
+$0.55 (+0.69%)
Updated
Jun 2 closing price
Net Assets
106.88B
VIGAX
Price
$214.25
Change
+$1.43 (+0.67%)
Updated
Jun 2 closing price
Net Assets
269.26B
Interact to see
Advertisement

JLGQX vs VIGAX

Header iconJLGQX vs VIGAX Comparison
Open Charts JLGQX vs VIGAXBanner chart's image
JPMorgan Large Cap Growth R4
Price$80.22
Change+$0.55 (+0.69%)
VolumeN/A
Net Assets106.88B
Vanguard Growth Index Admiral
Price$214.25
Change+$1.43 (+0.67%)
VolumeN/A
Net Assets269.26B
JLGQX vs VIGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JLGQX vs. VIGAX commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLGQX is a Buy and VIGAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 269B vs. JLGQX (107B). VIGAX pays higher dividends than JLGQX: VIGAX (0.46) vs JLGQX (0.00). JLGQX was incepted earlier than VIGAX: JLGQX (9 years) vs VIGAX (25 years). JLGQX (0.75) is less costly to investors than VIGAX (0.05). JLGQX is a more actively managed with annual turnover of: 32.00 vs. VIGAX (11.00). JLGQX has a lower initial minimum investment than VIGAX: JLGQX (0) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 17.83 vs. JLGQX (13.96). VIGAX return over 5 years is better than : 109.40 vs. JLGQX (69.90).
JLGQXVIGAXJLGQX / VIGAX
Total Expense Ratio0.690.051,380%
Annual Report Gross Expense Ratio0.750.051,500%
Fund Existence9 years25 years-
Gain YTD0.1890.75825%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets107B269B40%
Annual Yield % from dividends0.000.46-
Returns for 1 year13.9617.8378%
Returns for 3 years63.3670.0590%
Returns for 5 years69.90109.4064%
Returns for 10 yearsN/A281.47-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMRK20.821.09
+5.52%
A-Mark Precious Metals
GTBP2.710.13
+5.04%
GT Biopharma
GBTG6.340.09
+1.44%
Global Business Travel Group
XP19.490.13
+0.67%
XP
XTNT0.66N/A
+0.09%
Xtant Medical Holdings